首页> 外文期刊>Nephron >Carriers of Autosomal Recessive Alport Syndrome with Thin Basement Membrane Nephropathy Presenting as Focal Segmental Glomerulosclerosis in Later Life
【24h】

Carriers of Autosomal Recessive Alport Syndrome with Thin Basement Membrane Nephropathy Presenting as Focal Segmental Glomerulosclerosis in Later Life

机译:常染色体隐性遗传综合征伴薄基底膜肾病的携带者在以后的生活中表现为局灶性节段性肾小球硬化

获取原文
获取原文并翻译 | 示例
       

摘要

Collagen IV nephropathies (COL4Ns) comprise benign familial microscopic hematuria, thin basement membrane nephropathy (TBMN), X-linked Alport syndrome (AS) and also autosomal recessive and dominant AS. Apart from the X-linked form of AS, which is caused by hemizygous mutations in the COL4A5 gene, the other entities are caused by mutations in the COL4A3 or COL4A4 genes. The diagnosis of these conditions used to be based on clinical and/or histologicai findings of renal biopsies, but it is the new molecular genetics approach that revolutionised their investigation and proved particularly instrumental, especially, in many not so clear-cut cases. More recently, the spectrum of COL4N has expanded to include late onset focal segmental glomerulosclerosis (FSGS) that develops on top of TBMN in later life. Also, other reports showed that some patients with a primary diagnosis of familial FSGS proved to have variants in COL4 genes. In the presence of a renal biopsy picture of FSGS and in the absence of either electron microscopy studies or molecular genetic studies that point to TBMN and COL4N, the patient and his family may be mistakenly diagnosed with hereditary FSGS leading to unnecessary further investigations, erroneous family counselling and improper corticosteroid treatment. TBMN is a frequent finding in the general population, and according to several recent reports, it may be the underlying cause and the explanation for many familial and sporadic cases of late-onset FSGS with non-ne-phrotic proteinuria. This is an important new finding that needs widespread recognition. It is anticipated that the molecular genetic analysis with next generation sequencing will certainly offer timely correct diagnosis.
机译:胶原IV肾病(COL4Ns)包括良性家族性镜下血尿,薄基底膜肾病(TBMN),X连锁Alport综合征(AS)以及常染色体隐性和显性AS。除了AS的X连锁形式是由COL4A5基因的半合子突变引起的以外,其他实体是由COL4A3或COL4A4基因的突变引起的。这些疾病的诊断过去通常基于肾脏活检的临床和/或组织学发现,但是正是新的分子遗传学方法彻底改变了他们的研究方法,并证明了其特别的工具性,尤其是在许多不那么明确的案例中。最近,COL4N的范围已扩大到包括晚发的局灶节段性肾小球硬化症(FSGS),后者在TBMN的顶部发展。另外,其他报告显示,一些最初诊断为家族性FSGS的患者证明其COL4基因具有变异。如果存在FSGS的肾脏活检照片,并且缺乏针对TBMN和COL4N的电子显微镜检查或分子遗传学研究,则患者及其家人可能被误诊为遗传性FSGS,从而导致不必要的进一步检查,错误的家庭咨询和不正确的皮质类固醇治疗。 TBMN是普通人群中经常发现的疾病,根据最近的一些报道,它可能是许多晚发性FSGS伴非肾病蛋白尿的家族和散发病例的根本原因和解释。这是一个重要的新发现,需要得到广泛认可。预计采用下一代测序的分子遗传学分析必将提供及时的正确诊断。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号